By TopClassActions  |  September 9, 2013

Category: Pharmaceuticals
Follow us on Twitter and Facebook for the latest Januvia/Byetta Class Action Lawsuit & Settlement News!

 

New Byetta Thyroid Cancer Lawsuit Filed in Federal Court

By John Curran

 


Byetta thyroid cancer lawsuitA Florida woman claims in a new Byetta lawsuit filed August 23 that she was diagnosed with thyroid cancer, a condition she says was directly caused by her use of the type-2 diabetes medication.

Plaintiff Karen Brooks began taking Byetta in February 2008 for several months. About one year later, she was diagnosed with thyroid cancer, which necessitated medical care to minimize the spread of tumors. She is suing Byetta manufacturer Amylin Pharmaceuticals on counts of failure to warn, design defect, negligence, breaches of express and implied warranties, negligent misrepresentation and fraudulent concealment as well as violation of Florida state statutes.

To support the allegations, her Byetta thyroid cancer lawsuit notes that while there are no drug safety warnings regarding thyroid cancer as a side effect of Byetta, similar drugs carry well-publicized “black box” warnings from the FDA for similar issues. Victoza, a diabetes medication in the same drug class, was approved in 2010, but the FDA required post-marketing approvals and a clear warning regarding thyroid tumors, the lawsuit says.

Bydureon, another diabetes drug manufactured by Amylin Pharmaceuticals that is touted as “a long-acting form of the medication in Byetta” also carries a black box warning that it causes tumors in animal studies. However, the Byetta lawsuit alleges that the lack of information regarding Byetta thyroid cancer side effects, which occur 4.73 times more often than other treatments, puts numerous patients at risk for unforeseen conditions.

There are a number of lawsuits like that of Brooks that accuse Amylin and others of marketing a type-2 diabetes medication with carcinogenic properties. While thyroid cancer can be treated with some success, the medications have also been linked to pancreatic cancer side effects, which have a 5-percent survivability rate within five years of diagnosis.

The Byetta thyroid cancer lawsuit is Karen Brooks v. Amylin Pharmaceuticals, Case No. 13-cv-1974, U.S. District Court, Southern District of California.

Get Legal Help for Your Cancer Diagnosis

If you or someone you know has been diagnosed with conditions such as pancreatic cancer or thyroid cancer while taking a type-2 diabetes medication, get educated. A Byetta thyroid cancer lawsuit attorney can help review your case’s eligibility and help you determine whether or not to file a complaint. 

Learn more and get a free consultation by filling out the short form at the Type 2 Diabetes Drugs Januvia, Byetta Class Action Lawsuit Investigation today. You may be eligible for compensatory damages to offset lost quality of life, any medical bills and additional funds based on counts in a potential complaint.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.